Erectile Dysfunction Market Size, Share and Forecast 2026
The Erectile Dysfunction Market was worth the US $XX billion in 2018 and is expected to reach US $XX billion by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Erectile Dysfunction (ED) is one of the most common male sexual health disorder. ED affects physical and psychosocial health and significantly impacts on the quality of life (QoL) of patients and their partners. The primary symptom of the condition is the inability to attain or maintain firm erection during sexual intercourse. The disease can be classified as two broad sub-types - psychogenic and organic. Organic ED is gradual in onset whereas psychogenic ED is typically acute in onset.
Market Dynamics:
Rise in disease prevalence, advent of novel treatment modalities and improving treatment seeking rates owing to rise in treatment awareness will propel the market in forecast period. Low-treatment seeking pool (especially in developing countries), generic erosion of blockbuster ED drugs such as Viagra, Cialis and Levitra are major factors restraining the market growth.
Market Segmentation:
By Therapy Type
• Drug Therapy
• Topical Therapy
• Oral Therapy
• Others (Injectables & Suppositories)
• Device Therapy
• Penile Implants
• Vacuum Therapy Devices
• Others
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Bayer Inc
• Eli Lilly and Company
• Pfizer Inc.
• VIVUS, Inc
• Coloplast A/S
• Boston Scientific
• Others
View full report: https://www.datamintelligence.com/research-report/erectile-dysfunction-market
Download free sample: https://www.datamintelligence.com/download-sample/erectile-dysfunction-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Erectile Dysfunction (ED) is one of the most common male sexual health disorder. ED affects physical and psychosocial health and significantly impacts on the quality of life (QoL) of patients and their partners. The primary symptom of the condition is the inability to attain or maintain firm erection during sexual intercourse. The disease can be classified as two broad sub-types - psychogenic and organic. Organic ED is gradual in onset whereas psychogenic ED is typically acute in onset.
Market Dynamics:
Rise in disease prevalence, advent of novel treatment modalities and improving treatment seeking rates owing to rise in treatment awareness will propel the market in forecast period. Low-treatment seeking pool (especially in developing countries), generic erosion of blockbuster ED drugs such as Viagra, Cialis and Levitra are major factors restraining the market growth.
Market Segmentation:
By Therapy Type
• Drug Therapy
• Topical Therapy
• Oral Therapy
• Others (Injectables & Suppositories)
• Device Therapy
• Penile Implants
• Vacuum Therapy Devices
• Others
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key players:
• Bayer Inc
• Eli Lilly and Company
• Pfizer Inc.
• VIVUS, Inc
• Coloplast A/S
• Boston Scientific
• Others
View full report: https://www.datamintelligence.com/research-report/erectile-dysfunction-market
Download free sample: https://www.datamintelligence.com/download-sample/erectile-dysfunction-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results